100442-49-7 Usage
General Description
5-(Chloromethyl)-3-(trifluoromethyl)-1,2,4-oxadiazole is a chemical compound with the molecular formula C4H2ClF3N2O. It is a heterocyclic organic compound that contains oxygen, nitrogen, carbon, hydrogen, chlorine, and fluorine atoms. 5-(Chloromethyl)-3-(trifluoromethyl)-1,2,4-oxadiazole has potential applications in the fields of pharmaceuticals, agrochemicals, and material science. It is primarily used as an intermediate in the synthesis of various organic compounds and may also have some biological activity. However, further research is needed to fully understand its properties and potential uses.
Check Digit Verification of cas no
The CAS Registry Mumber 100442-49-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,4,4 and 2 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 100442-49:
(8*1)+(7*0)+(6*0)+(5*4)+(4*4)+(3*2)+(2*4)+(1*9)=67
67 % 10 = 7
So 100442-49-7 is a valid CAS Registry Number.
100442-49-7Relevant articles and documents
MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO
-
Page/Page column 194, (2012/11/07)
The present invention relates to compounds of Formula I and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as single pharmaceutical agents or in combination with one or more additional pharmaceutical agents, such as, a DPP-IV inhibitor, a biguanide, an alpha-glucosidase inhibitor, an insulin analogue, a sulfonylurea, an SGLT2 inhibitor, a meglitinide, a thiazolidinedione, or an anti-diabetic peptide analogue, in the treatment of, for example, a disorder selected from: a GPR119-receptor-related disorder; a condition ameliorated by increasing a blood incretin level; a condition characterized by low bone mass; a neurological disorder; a metabolic-related disorder; type 2 diabetes; obesity; and complications related thereto.
